decreasing the use of skin staples, increasing the use of incisional negative pressure wound therapy (NPWT) dressings, and implementing an elective decontamination protocol for methicillin-resistant Staphylococcus aureus. "Era 1" is defined as the time period between January 2012 and December 2013, prior to the implementation of infection control strategies; "era 2" is between January 2015 and August 2016, after implementation. The primary outcome of interest was 30-day dehiscence and/or infection. Multivariable logistic regression analysis was used to identify significant predictors of wound-related complications among the two cohorts. Propensity scoring was used to adjust for baseline patient characteristics, perioperative variables, and surgeon.
decreasing the use of skin staples, increasing the use of incisional negative pressure wound therapy (NPWT) dressings, and implementing an elective decontamination protocol for methicillin-resistant Staphylococcus aureus. "Era 1" is defined as the time period between January 2012 and December 2013, prior to the implementation of infection control strategies; "era 2" is between January 2015 and August 2016, after implementation. The primary outcome of interest was 30-day dehiscence and/or infection. Multivariable logistic regression analysis was used to identify significant predictors of wound-related complications among the two cohorts. Propensity scoring was used to adjust for baseline patient characteristics, perioperative variables, and surgeon.
Results: A total of 338 open infrainguinal procedures were performed: 175 in era 1 and 163 in era 2. Chlorhexidine was used in the 321 cases (95%). Comparing the time periods, era 2 is characterized by an increase in prosthetic graft use (30 [17%] Objectives: There has been a recent push for early discharge of elective endovascular abdominal aortic aneurysm repair (EVAR). However, a large proportion of EVAR patients are still routinely admitted to the intensive care unit (ICU) for observation. In the current study, we aimed to describe the factors associated with ICU admission post-EVAR and to compare the outcomes and costs associated with ICU vs non-ICU observation.
Methods: All patients undergoing elective EVAR in the Premier Database (2009) (2010) (2011) (2012) (2013) (2014) (2015) were included. Patients were stratified as ICU vs non-ICU according to admission location on postoperative day 0. Both patient-level (sociodemographic, comorbidities) and hospital-level (teaching status, hospital size, geographic location) factors were analyzed using univariable and multivariable logistic regression to determine factors associated with ICU vs non-ICU admission. Overall hospital costs were then compared between groups.
Results: Overall, 8359 patients underwent elective EVAR during the study period, including 4791 ICU (57.3%) and 3568 non-ICU (42.7%) admissions. Patients admitted to ICU were more frequently nonwhite and had more comorbidities, including congestive heart failure, coronary artery disease, chronic kidney disease, chronic obstructive pulmonary disease, diabetes, and hypertension (P < .03). ICU admissions were more common in small (<300 beds), urban, nonteaching hospitals and varied greatly by geographic region (P < .001, Fig 1) . Notably, there was a significant discrepancy in hospital ICU admission patterns between groups: ICU patients were treated at hospitals where 96.7% (interquartile range, 84.5%-98.9%) of patients were admitted to ICU post-EVAR, whereas non-ICU patients were treated at hospitals where only 7.5% (interquartile range, 4.9%-25.8%) were admitted to ICU post-EVAR. A multivariable logistic regression model accounting for patient-, operative, and hospitallevel differences (model 1) had a significantly lower area under the curve (AUC) for predicting ICU admission post-EVAR than a model accounting only for percentage of post-EVAR ICU admissions per hospital (AUC, 0.76 vs 0.95; P < .001, Fig 2) . After adjusting for patient and hospital factors and adverse events, ICU admission after uncomplicated EVAR cost $1475 (95% confidence interval, $768-$2183) more than non-ICU (P < .001). The overall rate of adverse events was higher for ICU vs non-ICU patients (16.3% vs 13.7%; P < .001). Failure to rescue (2.9% vs 3.9%; P ¼ .42) and mortality (0.4% vs 0.4%; P ¼ .81) were similar between groups.
Conclusions: Among patients undergoing elective EVAR, the decision to admit to ICU appears to be based primarily on hospital practice patterns rather than individual patient risk. ICU admission post-EVAR adds significant cost without reducing failure to rescue or mortality. Future studies should focus on creating a decision model to discern the costeffectiveness for ICU vs non-ICU admission on a patient-by-patient basis. 
VESS11.
Lower Extremity Bypass and Endovascular Intervention for Critical Limb Ischemia Fail to Meet Society for Vascular Surgery's Objective Performance Goals for Limb-Related Outcomes in a Contemporary National Cohort Objectives: In 2009, the Society for Vascular Surgery (SVS) developed objective performance goals (OPGs) to define the therapeutic benchmarks for catheter-based revascularization in critical limb ischemia (CLI) based upon outcomes from randomized trials of lower extremity bypass (SVS OPG cohort). Current real-world performance relative to these benchmarks remains unknown. The objective of this study was to determine whether lower extremity bypass (LEB) and infrainguinal endovascular intervention (IEI) performed for CLI in a contemporary national cohort met OPG safety benchmarks.
Methods: SVS OPG criteria were applied to 11,043 revascularizations for CLI performed from 2011 to 2015 in the National Surgical Quality Improvement Project (NSQIP) vascular-targeted modules. Primary 30-day safety OPGs, including major adverse cardiac events (MACE), major adverse limb events (MALE), and amputation, were calculated for all OPG-eligible NSQIP LEB (bypass with single-segment saphenous vein, n ¼ 3,835; Table I ) and IEI (defined as angioplasty, stenting, and/or atherectomy, n ¼ 3,526; Table I ) cohorts and within anatomic high-risk (infrapopliteal disease) and clinical high-risk (age >80 and tissue loss) cohorts defined by SVS OPG criteria. These were compared with SVS OPGs using c 2 comparisons. Results: Compared with the SVS OPG cohort, the NSQIP LEB and IEI cohorts had fewer anatomic high-risk patients (LEB: 51% vs SVS OPG 60%; P < .0001; IEI: 17% vs SVS OPG: 60%; P < .0001), and the LEB cohort had fewer clinical high-risk patients (LEB: 11% vs SVS OPG: 16%; P < .0001). In the OPG-eligible NSQIP cohorts, LEB and IEI were associated with lower 30-day MACE but higher 30-day MALE and amputation compared with the SVS OPG cohort (Table II) . Among anatomic high-risk patients, the NSQIP LEB and IEI cohorts again had lower MACE and higher MALE and amputation compared with the SVS OPG cohort (Table II) . Among clinical high-risk patients, IEI was associated with lower MACE, and LEB and IEI had MALE and amputation similar to the SVS OPG cohort (Table II) .
Conclusions: In contemporary real-world practice, LEB and IEI for CLI surpassed SVS OPG safety benchmarks for MACE but failed to meet SVS OPG safety benchmarks for MALE and amputation in the entire OPG-eligible NSQIP cohort as well as in anatomic high-risk patients. Revascularization for CLI is now associated with lower cardiovascular morbidity than anticipated based on OPG trial data, and OPG benchmarks deserve further evaluation. Additional investigation is needed to determine why limb-related outcomes after bypass and endovascular intervention for CLI remain suboptimal. Objectives: Over the last 15 years, the demographic and clinical characteristics of surgical patients have changed. During this period, endovascular surgery has also supplanted open surgical bypass as the most frequently used approach in patients with atherosclerotic disease of the aortoiliac segment. We sought to determine whether these trends in patients undergoing aortofemoral bypass (AFB) for aortoiliac occlusive disease (AOD) have impacted the patient profile and outcomes following surgical bypass.
Methods: Using a prospectively maintained institutional database, we identified patients who underwent AFB for AOD. Patients were divided into two cohorts: the historical cohort (HC), 1985 to 1999, and the contemporary cohort (CC), 2000 to 2015. Demographic and clinical data, procedural information, postoperative complications, and follow-up were extracted. Two-group comparison of continuous variables was performed using the Student t-test or Wilcoxon rank sum based on normality of distribution, c 2 for discrete variables, and logrank for survival analysis.
Results: There were a total of 359 cases: 226 in the HC and 133 cases in the CC. The CC had more women (56.4% vs 43.8%; P ¼ .02) smokers 
